Leptin
- Generic Name
- Leptin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- -
- CAS Number
- 169494-85-3
- Unique Ingredient Identifier
- Q09SXY6BFI
- Background
Although leptin is a circulating signal that reduces appetite, in general, obese people have an unusually high circulating concentration of leptin. These people are said to be resistant to the effects of leptin, in much the same way that people with type 2 diabetes are resistant to the effects of insulin. Thus, obesity develops when people take in more energ...
- Indication
Investigated for use/treatment in lipodystrophy and obesity.
- Associated Conditions
- -
- Associated Therapies
- -
Effects of Leptin Treatment on Weight Loss
- First Posted Date
- 2002-12-23
- Last Posted Date
- 2010-10-19
- Lead Sponsor
- Rockefeller University
- Target Recruit Count
- 40
- Registration Number
- NCT00050791
- Locations
- 🇺🇸
Rockefeller University Hospital, New York, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath